Atacor Medical, Inc. applications

Conduction abnormalities, whether transitory or persistent, develop in approximately 90% of patients who experience a myocardial infarction.² The AtaCor EV Temporary Pacing System is designed to support stable pacing of new-onset arrhythmias to help guide treatment decisions and optimize patient care: